- Home
- WYY vs CASI Comparison
WYY vs CASI Comparison
Compare WYY & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- CASI
- Stock Information
- Founded
- WYY 1991
- CASI 1991
- Country
- WYY United States
- CASI China
- Employees
- WYY N/A
- CASI N/A
- Industry
- WYY EDP Services
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- CASI Health Care
- Exchange
- WYY Nasdaq
- CASI Nasdaq
- Market Cap
- WYY 35.6M
- CASI 29.7M
- IPO Year
- WYY 1998
- CASI 1996
- Fundamental
- Price
- WYY $3.01
- CASI $1.89
- Analyst Decision
- WYY Strong Buy
- CASI Strong Buy
- Analyst Count
- WYY 1
- CASI 1
- Target Price
- WYY $7.00
- CASI $4.00
- AVG Volume (30 Days)
- WYY 210.9K
- CASI 7.1K
- Earning Date
- WYY 05-15-2025
- CASI 05-16-2025
- Dividend Yield
- WYY N/A
- CASI N/A
- EPS Growth
- WYY N/A
- CASI N/A
- EPS
- WYY N/A
- CASI N/A
- Revenue
- WYY $142,582,209.00
- CASI $31,368,000.00
- Revenue This Year
- WYY $10.84
- CASI N/A
- Revenue Next Year
- WYY $12.37
- CASI N/A
- P/E Ratio
- WYY N/A
- CASI N/A
- Revenue Growth
- WYY 24.03
- CASI 8.39
- 52 Week Low
- WYY $2.19
- CASI $1.64
- 52 Week High
- WYY $6.25
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- WYY 35.88
- CASI 47.25
- Support Level
- WYY $2.90
- CASI $1.77
- Resistance Level
- WYY $3.27
- CASI $1.98
- Average True Range (ATR)
- WYY 0.49
- CASI 0.10
- MACD
- WYY -0.22
- CASI 0.01
- Stochastic Oscillator
- WYY 5.06
- CASI 54.55
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.